Strategy

We are a Nordic evergreen life science investment firm, investing off our own balance sheet to build
pioneering companies and commercialize solutions for patients worldwide. We aim to be invested as long as we will contribute and build value, and apply our active ownership model in four main ways that have proven to help our companies develop their pipeline:

Being active board members

  • Utilising expertise to influence and steer
  • Providing practical support to portfolio CEO’s
  • Identifying gaps and plugging those holes via our network

Planning ahead together

  • Establishing product development road maps and paths to commercialisation
  • Encouraging technology platform expansion within the means of funding or via partnerships

Facilitating peer-to-peer exchange

  • The ‘Flerie and Peers’ network allows CEOs to bond and continue their own exchanges
  • This international network provides warm introductions and new ways to tackle SME hurdles

Leveraging collaborations

  • Providing a conduit for collaboration across the portfolio companies
  • Encouraging the use of shared resources of production, clinical studies and human capital/consultants
  • Discovering synergies